A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main purpose of this study is to evaluate safety and reactogenicity of the investigational pneumococcal vaccine (called Pn-MAPS30plus). PCV20 will be used as a comparator for this study
Epistemonikos ID: 004bc5c01b72a25e15937b4bcc6e6bc2193bdc8d
First added on: Feb 13, 2026